Clinical trials data
Verbal Learning in stroke trials: 63 registered studies
Every registered stroke study on ClinicalTrials.gov that names Verbal Learning in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered stroke studies name it in an outcome measure
- 63
- Name it in a primary outcome, 30%
- 19 of 63
Tests named in the same studies
- 1
Verbal Fluency30 studies, 10 as a primary outcome
- 2
Trail Making Test29 studies, 8 as a primary outcome
- 3
Digit Span Test28 studies, 6 as a primary outcome
- 4
Stroop Color-Word Test17 studies, 1 as a primary outcome
- 5
Picture Naming Test12 studies, 5 as a primary outcome
- 6
Symbol Coding11 studies, 3 as a primary outcome
- 7
Category Fluency9 studies, 3 as a primary outcome
- 8
Complex Figure Copy and Recall7 studies, 2 as a primary outcome
- 9
Short Story Recall6 studies, 1 as a primary outcome
- 10
Corsi Block-Tapping Test4 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 0 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 3 | 2 |
| 2014 | 2 | 1 |
| 2015 | 4 | 0 |
| 2016 | 2 | 1 |
| 2017 | 4 | 1 |
| 2018 | 3 | 0 |
| 2019 | 1 | 0 |
| 2020 | 6 | 3 |
| 2021 | 6 | 3 |
| 2022 | 6 | 4 |
| 2023 | 4 | 3 |
| 2024 | 3 | 0 |
| 2025 | 11 | 1 |
| 2026 | 2 | 0 |
Phases and study sizes
By phase
- Phase 12 studies, 0 as a primary outcome
- Phase 1/21 studies, 0 as a primary outcome
- Phase 26 studies, 3 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 41 studies, 0 as a primary outcome
- Not applicable39 studies, 11 as a primary outcome
- Observational11 studies, 4 as a primary outcome
Participants per study
- Not applicable41 median, 20 to 84
- Observational112 median, 100 to 225
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 37 | 41 | 20 to 84 |
| Observational | 11 | 112 | 100 to 225 |
When stroke trials measure it
Latest time point of each outcome
- Within a day9 outcomes, 4 as a primary outcome
- Up to 4 weeks8 outcomes, 0 as a primary outcome
- 1 to 3 months17 outcomes, 4 as a primary outcome
- 3 to 6 months7 outcomes, 3 as a primary outcome
- 6 to 12 months12 outcomes, 4 as a primary outcome
- 1 to 2 years5 outcomes, 2 as a primary outcome
- Over 2 years4 outcomes, 2 as a primary outcome
- No duration given1 outcomes, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
62 of the 63 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting16 studies, 4 as a primary outcome
- Not yet recruiting2 studies, 0 as a primary outcome
- Active, not recruiting3 studies, 1 as a primary outcome
- Completed29 studies, 9 as a primary outcome
- Stopped early2 studies, 2 as a primary outcome
- Status unknown11 studies, 3 as a primary outcome
What they test
- Behavioral18 studies, 5 as a primary outcome
- Drug11 studies, 6 as a primary outcome
- Device16 studies, 4 as a primary outcome
- Procedure10 studies, 4 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological3 studies, 0 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Genetic1 studies, 0 as a primary outcome
- Other11 studies, 2 as a primary outcome
- None given2 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States22 studies, 8 as a primary outcome
- Spain5 studies, 1 as a primary outcome
- Sweden5 studies, 2 as a primary outcome
- China4 studies, 2 as a primary outcome
- Netherlands4 studies, 1 as a primary outcome
- Norway4 studies, 0 as a primary outcome
- Canada2 studies, 0 as a primary outcome
- Russia2 studies, 0 as a primary outcome
- Singapore2 studies, 0 as a primary outcome
- Australia1 studies, 1 as a primary outcome
- Brazil1 studies, 0 as a primary outcome
- Cyprus1 studies, 1 as a primary outcome
18 countries in all. A study with sites in several counts in each; 4 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed stroke studies that name Verbal Learning: 13 of 29, 45%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed stroke studies that name Verbal Learning | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 3% | 776, 10% |
| Results on ClinicalTrials.gov only | 5, 17% | 1,139, 14% |
| A results paper only | 7, 24% | 1,711, 22% |
| Neither | 16, 55% | 4,327, 54% |
The 63 studies
63 studies match. 19 name Verbal Learning in a primary outcome. Median size 60 participants. Median time to the primary outcome: 6 months.
Loading 63 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 0 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 3 | 2 |
| 2014 | 2 | 1 |
| 2015 | 4 | 0 |
| 2016 | 2 | 1 |
| 2017 | 4 | 1 |
| 2018 | 3 | 0 |
| 2019 | 1 | 0 |
| 2020 | 6 | 3 |
| 2021 | 6 | 3 |
| 2022 | 6 | 4 |
| 2023 | 4 | 3 |
| 2024 | 3 | 0 |
| 2025 | 11 | 1 |
| 2026 | 2 | 0 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 6, other 57. Interventional 52, observational 11.
As a primary outcomeSecondary or other outcomeVerbal Learning
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07719387 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07624630 | Start2026 | PhaseObservational | ConditionsStroke, Aging, frailty and exercise | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07541560 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07429526 | Start2013 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion, Pain and fatigue | Participants12 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07396025 | Start2025 | PhaseNot applicable | ConditionsStroke, Cardiovascular disease | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07345481 | Start2026 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07252544 | Start2025 | PhasePhase 3 | ConditionsStroke | Participants3,156 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07119827 | Start2025 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants250 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07030985 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants55 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06876597 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants1,047 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06800040 | Start2025 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06774287 | Start2025 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion | Participants6 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06612710 | Start2025 | PhasePhase 1 | ConditionsStroke | Participants69 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06556316 | Start2020 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants200 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06471127 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06336174 | Start2022 | PhaseObservational | ConditionsStroke, Cardiovascular disease | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06330298 | Start2021 | PhaseNot applicable | ConditionsStroke, Multiple sclerosis, Cancer | Participants84 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06214364 | Start2024 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion | Participants36 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06076928 | Start2024 | PhaseNot applicable | ConditionsStroke | Participants13 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06021470 | Start2023 | PhaseNot applicable | ConditionsStroke | Participants64 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05951777 | Start2024 | PhasePhase 2 | ConditionsStroke, Brain injury and concussion, Cancer | Participants51 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT05929287 | Start2023 | PhaseNot applicable | ConditionsStroke | Participants30 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05908994 | Start2021 | PhaseObservational | ConditionsStroke | Participants100 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05819008 | Start2023 | PhaseObservational | ConditionsStroke, Brain injury and concussion, Parkinson's disease, Multiple sclerosis, Cancer, Epilepsy | Participants350 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05584605 | Start2022 | PhaseNot applicable | ConditionsStroke | Participants40 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many stroke trials use Verbal Learning?
63 registered stroke studies on ClinicalTrials.gov name it in an outcome measure, 19 of them in a primary outcome: 5% of the condition's 1,233 studies with a cognitive outcome, against 11% of all of them. It is the 7th most named test in stroke trials.
Which tests do stroke trials use with Verbal Learning?
Verbal Fluency (30 studies), the Trail Making Test (29 studies) and the Digit Span Test (28 studies).
When do stroke trials measure Verbal Learning?
Half of the primary outcomes that name Verbal Learning are measured within 6 months of the start, and the middle half from 12 weeks to 12 months. 19 primary outcomes give a duration.
How many completed stroke trials that use Verbal Learning have reported results?
13 of the 29 completed studies that name it, 45%, have reported results: 6 posted them on ClinicalTrials.gov, 8 have a results paper linked to the registry record, and 1 did both. The other 16 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Verbal Learning and Grocery Trip Game as one test family, so this page counts their studies together.
Run Verbal Learning in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.